ANIXA BIOSCIENCES INC (ANIX) Stock Earnings & Estimates
USA - NASDAQ:ANIX - US03528H1095 - Common Stock
4.4 USD
+0.05 (+1.15%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 510K | -100.00% | 210K | -100.00% | 7.684M | 48.611M 532.63% | 124.33M 155.77% | 453.52M 264.77% | |||||
| EBITDA YoY % growth | -12.75M -28.27% | N/A | -10.804M | N/A -27.67% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -12.75M -27.76% | -13.88M -8.86% | -10.85M 21.83% | -14.206M -27.47% | -13.238M 4.29% | -14.106M -6.56% | -15.465M -9.63% | -16.612M -7.42% | -10.468M 36.99% | 28.727M 374.44% | 94.907M 230.38% | 413.53M 335.72% | |
| Operating Margin | -2,500.00% | N/A | -5,166.67% | N/A | N/A | N/A | N/A | N/A | -136.23% | 59.10% | 76.33% | 91.18% | |
| EPS YoY % growth | -0.44 0.00% | -0.46 -4.55% | -0.32 30.43% | -0.40 -21.88% | -0.36 8.46% | -0.34 4.76% | -0.31 10.00% | -0.35 -13.33% | -0.35 | -0.26 26.47% | 0.10 140.00% | 0.71 600.00% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 5.56% | -0.10 3.10% | -0.10 -13.33% | -0.11 -53.00% | -0.11 -32.01% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.506M -10.84% | -3.086M 8.87% | -3.219M -7.20% | -3.487M -43.16% | -4.044M -15.36% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.07 30.00% | -0.09 | 0.02 | 23.75% |
| Q2 2025 Q2Q % growth | -0.09 10.00% | -0.10 | 0.01 | 11.76% |
| Q1 2025 Q2Q % growth | -0.10 | -0.10 | 0.00 | 1.96% |
| Q4 2024 Q2Q % growth | -0.09 | -0.09 | 0.00 | -3.81% |
| Q3 2024 Q2Q % growth | -0.10 -25.00% | -0.10 | 0.00 | -3.20% |
| Q2 2024 Q2Q % growth | -0.10 -42.86% | -0.11 | 0.01 | 10.87% |
| Q1 2024 Q2Q % growth | -0.10 -25.00% | -0.09 | -0.01 | -8.93% |
| Q4 2023 Q2Q % growth | -0.09 25.00% | -0.09 | 0.00 | 1.96% |
| Q3 2023 Q2Q % growth | -0.08 11.11% | -0.09 | 0.01 | 12.85% |
| Q2 2023 Q2Q % growth | -0.07 41.67% | -0.12 | 0.05 | 40.32% |
| Q1 2023 Q2Q % growth | -0.08 38.46% | -0.16 | 0.08 | 50.98% |
| Q4 2022 Q2Q % growth | -0.12 7.69% | -0.11 | -0.01 | -6.95% |
| Q3 2022 Q2Q % growth | -0.09 35.71% | -0.13 | 0.04 | 32.13% |
| Q2 2022 Q2Q % growth | -0.12 -50.00% | -0.13 | 0.01 | 9.50% |
| Q1 2022 Q2Q % growth | -0.13 -44.44% | -0.13 | 0.00 | 1.96% |
| Q4 2021 Q2Q % growth | -0.13 -44.44% | -0.09 | -0.04 | -41.61% |
| Q3 2021 Q2Q % growth | -0.14 -40.00% | -0.08 | -0.06 | -71.57% |
| Q2 2021 Q2Q % growth | -0.08 33.33% | -0.11 | 0.03 | 25.30% |
| Q1 2021 Q2Q % growth | -0.09 30.77% | -0.11 | 0.02 | 19.79% |
| Q4 2020 Q2Q % growth | -0.09 10.00% | -0.11 | 0.02 | 15.97% |
| Q3 2020 Q2Q % growth | -0.10 9.09% | -0.13 | 0.03 | 21.57% |
| Q2 2020 Q2Q % growth | -0.12 7.69% | -0.13 | 0.01 | 5.88% |
| Q1 2020 Q2Q % growth | -0.13 43.48% | -0.13 | 0.00 | 1.96% |
| Q4 2019 Q2Q % growth | -0.10 | -0.24 | 0.14 | 59.15% |
| Q3 2019 Q2Q % growth | -0.11 | -0.23 | 0.12 | 53.11% |
| Q2 2019 Q2Q % growth | -0.13 | -0.23 | 0.10 | 44.59% |
| Q1 2019 Q2Q % growth | -0.23 | -0.15 | -0.08 | -50.33% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | -100.00% | % | ||
| Q1 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2020 Q2Q % growth | -100.00% | 287.13K | -287.13K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -4.16% | 20.64% | 4.11% | 11.39% |
| Revenue | N/A | N/A | N/A | N/A |